Daewoong Pharmaceutical Co.,Ltd sell "URSA"
Basic Information
41
2
4.2(13)
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
URSA
Manufacturer(s)
Specifications
- Formulation Type: Available as tablets, soft capsules and hard capsules in 25, 50, 100, 200, 250 and 300 mg strengths of UDCA
- Application: Treatment of cholestasis (including PBC and PSC), viral hepatitis C, and gallstones
- Regulatory Status: UDCA is the only drug approved by the US FDA specifically for primary biliary cholangitis (PBC)
- Storage Condition: Store below 25°C in a tightly sealed container, protected from moisture
Other Information
Additional Description:
Available as tablets, soft capsules and hard capsules in 25, 50, 100, 200, 250 and 300 mg strengths of UDCA (ursodeoxycholic acid), indicated for cholestasis (including PBC and PSC), viral hepatitis C, and gallstones. URSA improves liver function in chronic hepatitis patients and improves symptoms and histopathology in cholestasis patients; UDCA is the only drug approved by the US FDA for PBC.
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment